Pharmacokinetics of ceftriaxone in healthy horses.

This research explores the behavior and effectiveness of an antibiotic drug, ceftriaxone, in healthy horses, and suggests its potential usefulness in treating bacterial infections, particularly bacterial meningitis, as it can penetrate cerebrospinal fluid.

Overview of Methodology and Research Process

• Five healthy members of the Equidae family (four horses and one pony) were selected as the subjects of this study.
• Each subject was administered a single intravenous dose of ceftriaxone at a ratio of 50 mg per kg of body weight.
• Both blood and cerebrospinal fluid (CSF) samples were collected using intravenous jugular catheter and pre-placed intrathecal catheter respectively.
• The concentration levels of ceftriaxone in both serum and CSF were determined through high performance liquid chromatography.

Findings and Key Outcomes

• Results revealed that the average serum concentration of ceftriaxone was 144.7 micrograms per ml 15 minutes after injection. This concentration decreased to 0.3 microgram per ml 10 hours after injection.
• The researchers calculated key pharmacokinetic parameters including the elimination rate constant, the elimination half-life, the apparent volume of distribution at steady state, clearance, and mean residence time. These figures provide insights into how the ceftriaxone is metabolized and excreted in the horses’ bodies.
• Results showed that ceftriaxone was present in the cerebrospinal fluid with an average concentration of 0.60 micrograms per ml at 3 hours and 0.4 micrograms per ml at 8 hours post injection. This indicates the drug’s ability to penetrate the CSF.

Concluding Remarks and Future Implications

• Based on its pharmacokinetic profile and its ability to penetrate the cerebrospinal fluid in horses, ceftriaxone could be potentially useful in treating bacterial infections in horses, particularly bacterial meningitis.
• However, further studies may be required to study the clinical effectiveness and potential side effects of ceftriaxone in equine patients, as well to establish appropriate dosage guidelines for different conditions.